Paul Workman
Impact in
- Toxicology top 0.02%
- Cancer Research top 0.2%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Heat shock proteins research 116
- Cancer therapeutics and mechanisms 54
- Protein Degradation and Inhibitors 44
- PI3K/AKT/mTOR signaling in cancer 41
- Cancer Research 109
- Cancer, Hypoxia, and Metabolism 64
- Co-authors
- Paul Andrew Clarke (69 shared papers)Bissan Al‐Lazikani (26 shared papers)Udai Banerji (20 shared papers)Marissa V. Powers (13 shared papers)Florence I. Raynaud (60 shared papers)Swee Y. Sharp (37 shared papers)Michael I. Walton (35 shared papers)Ian F. Collins (20 shared papers)
- Journals
- British Journal of Cancer (51 papers)Biochemical Pharmacology (33 papers)Cancer Research (32 papers)Molecular Cancer Therapeutics (28 papers)Cancer Chemotherapy and Pharmacology (28 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Paul Workman
598 papers receiving 37.7k citations
Paul Workman's Hit Papers
Peers
Comparison fields: 5 of 172
- Toxicology 1.4k
- Cancer Research 5.5k
- Molecular Biology 23.4k
- Oncology 7.8k
- Genetics 2.2k
Countries citing papers authored by Paul Workman
This map shows the geographic impact of Paul Workman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Workman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Workman more than expected).
Fields of papers citing papers by Paul Workman
This network shows the impact of papers produced by Paul Workman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Workman. The network helps show where Paul Workman may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Workman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 601 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Patient-derived organoids model treatment response of metastatic gastrointestinal cancers Hit paper breakdown → | 2018 | 1589 |
| 2 | Guidelines for the welfare and use of animals in cancer research Hit paper breakdown → | 2010 | 1211 |
| 3 | Imaging biomarker roadmap for cancer studies Hit paper breakdown → | 2016 | 877 |
| 4 | Combinatorial drug therapy for cancer in the post-genomic era Hit paper breakdown → | 2012 | 859 |
| 5 | Challenges to curing primary brain tumours Hit paper breakdown → | 2019 | 728 |
| 6 | The Identification of 2-(1 H -Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2- d ]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer Hit paper breakdown → | 2008 | 681 |
| 7 | 2002 | 480 | |
| 8 | 2012 | 480 | |
| 9 | 2008 | 475 | |
| 10 | 2007 | 465 | |
| 11 | 2002 | 445 | |
| 12 | 2005 | 435 | |
| 13 | 2005 | 420 | |
| 14 | 2008 | 415 | |
| 15 | 2007 | 394 | |
| 16 | 2008 | 376 | |
| 17 | 2017 | 315 | |
| 18 | 2006 | 314 | |
| 19 | 1999 | 313 | |
| 20 | 2007 | 312 |
About Paul Workman
Paul Workman is a scholar working on Molecular Biology, Cancer Research, Oncology, Computational Theory and Mathematics and Pharmacology, having authored 601 papers that have together received 39.3k indexed citations. Recurring topics across this work include Heat shock proteins research (116 papers), Computational Drug Discovery Methods (75 papers), Cancer, Hypoxia, and Metabolism (64 papers), Cancer therapeutics and mechanisms (54 papers), Cancer-related Molecular Pathways (46 papers), Protein Degradation and Inhibitors (44 papers), Pharmacogenetics and Drug Metabolism (42 papers) and PI3K/AKT/mTOR signaling in cancer (41 papers). The work is most often cited by research in Toxicology (1.4k citations), Cancer Research (5.5k citations), Molecular Biology (23.4k citations), Oncology (7.8k citations) and Genetics (2.2k citations). Paul Workman has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Paul Andrew Clarke, Bissan Al‐Lazikani, Udai Banerji, Marissa V. Powers, Florence I. Raynaud, Swee Y. Sharp, Michael I. Walton, Ian F. Collins, Alison Maloney and Michelle Dawn Garrett. Their work appears in journals such as British Journal of Cancer, Biochemical Pharmacology, Cancer Research, Molecular Cancer Therapeutics and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.